ISPOR Good Practice Task Force Recommendations on Valuing HRQoL of Children & Adolescents in Economic Evaluation (Pediatric Utilities)
Author(s)
Moderator: Nancy Joy Devlin, PhD, School of Population and Global Health, University of Melbourne, Melbourne, Australia
Speakers: Louis Matza, PhD, Patient-Centered Research, Evidera, Bethesda, MD, USA; Ernest H Law, PharmD, PhD, Global HEOR, Pfizer, New York, NY, USA; Fleur Chandler, MSc, Sanofi and Patient Advisory Board Lead, Duchenne UK, Reading, Berkshire, Great Britain
This forum will highlight the principal methods issues concerning:
- Whose stated preferences are relevant to the preference weighting of pediatric HRQoL states?
- What perspective respondents should be asked to adopt in imagining and valuing pediatric HRQoL?
- What preference elicitation methods should be used? and
- To what extent is the comparability and consistency of health state utilities for adult and child HRQoL important for their use in QALY estimation, economic evaluation and decision making?
The task force will present their recommendations and seek audience feedback on the overall approach taken. Pediatric utilities inevitably involves both HEOR science and normative considerations. Given the pivotal role of value judgements in methods choices in pediatric utilities, consultation with local HTA bodies is essential both to ensure that utilities are ‘fit for purpose’, and to ensure that decision makers are well informed about the role and implications of value judgements when establishing methods guidelines. The session will conclude with a question and answer session.
Conference/Value in Health Info
Code
218
Topic
Patient-Centered Research